Covered recipient · General Payments record
STEVE SIMPSON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$4,157.48
- Reported across 289 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $392.15 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $172.84 | 13 |
| Astellas Pharma US Inc | $55.05 | 3 |
| PFIZER INC. | $49.19 | 3 |
| GlaxoSmithKline, LLC. | $32.22 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $22.09 | 1 |
| Amgen Inc. | $17.35 | 1 |
| Mylan Specialty L.P. | $16.60 | 1 |
| SANOFI-AVENTIS U.S. LLC | $13.56 | 1 |
| Lilly USA, LLC | $13.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.06 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106107411 | CMS |
| ABBVIE INC. | $19.16 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106107413 | CMS |
| ABBVIE INC. | $13.40 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106107415 | CMS |
| ABBVIE INC. | $4.22 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106107417 | CMS |
| ABBVIE INC. | $26.73 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106107419 | CMS |
| ABBVIE INC. | $18.37 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106107421 | CMS |
| ABBVIE INC. | $15.28 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106107423 | CMS |
| ABBVIE INC. | $4.79 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106107425 | CMS |
| ABBVIE INC. | $20.16 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106107427 | CMS |
| ABBVIE INC. | $9.80 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106107429 | CMS |
| ABBVIE INC. | $16.02 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106107431 | CMS |
| ABBVIE INC. | $2.13 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106107433 | CMS |
| ABBVIE INC. | $5.72 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106107435 | CMS |
| Amgen Inc. | $17.35 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117684892 | CMS |
| Astellas Pharma US Inc | $15.88 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139296876 | CMS |
| Astellas Pharma US Inc | $14.25 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139358159 | CMS |
| Astellas Pharma US Inc | $24.92 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139435906 | CMS |
| GlaxoSmithKline, LLC. | $14.73 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116360230 | CMS |
| GlaxoSmithKline, LLC. | $17.49 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115981141 | CMS |
| Lilly USA, LLC | $13.25 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135433377 | CMS |
| Mylan Specialty L.P. | $16.60 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147307810 | CMS |
| PFIZER INC. | $16.80 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131288581 | CMS |
| PFIZER INC. | $16.09 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131761826 | CMS |
| PFIZER INC. | $16.30 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131838338 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $22.09 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153460923 | CMS |
| SANOFI-AVENTIS U.S. LLC | $13.56 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139628811 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.